Sonoma Pharma
SNOA1.1003.51% ( -0.040 )
Sonoma Pharma (SNOA)
Sonoma Pharmaceuticals, Inc. develops and produces stabilized hypochlorous acid (HOCl) products for wound and eye care, oral and nasal care, podiatry, animal he...
- Open
- 1.180
- High
- 1.210
- Low
- 1.100
- Prev. Close
- 1.140
- Volume
- 35.91K
- Turnover
- 40.82K
- Avg Price
- 1.137
- Bid/Ask Ratio
- --
- Amplitude
- 9.65%
- 52wk High
- 6.920
- Volume Ratio
- 1.34
- Turnover Ratio
- 2.09%
Sonoma Pharma Analyst Rating
View MoreForecast & Rating
Feb 8, 2026Price forecast
$12.00990.91%
Forecast & Rating-
0analysts
News
- PUBT · 1 day ago, 03:52 PM
Sonoma Pharmaceuticals announces annual shareholder meeting
- PUBT · Jun 30 at 08:01 AM
Sonoma Pharma wins FDA 510(k) clearance expanding Microdacyn wound solution indications
- Tip Ranks · Jun 18 at 05:41 PM
Sonoma Pharmaceuticals Expands At-the-Market Equity Offering Capacity
- PUBT · Jun 18 at 03:34 PM
Sonoma Pharma ups at-the-market stock offering to $3.64 million
- StockTitan · Jun 16 at 07:15 AM
Sonoma Pharmaceuticals Reports Fiscal Year and Fourth Quarter 2026 Financial Results | SNOA Stock News
- benzinga_article · May 1 at 01:20 PM
Sonoma Pharmaceuticals shares are trading higher after the company entered an agreement with Dawson James Securities to sell 2,962,962 units at $1.35 per unit.
